US › Healthcare

BeyondSpring Inc (BYSI)

US · Healthcare · Biotechnology

$0.99-15.38%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-2.2M

Profit YoY

-148.2%

EPS

$-0.05

EPS estimate

$0.00

Key statistics

Market cap

$48.1M

Forward P/E

10.5

P/B

5.38

Book value

$-0.84

EPS (TTM)

$-0.20

52-week high

$2.44

52-week low

$0.99

50-day MA

$1.52

200-day MA

$1.66

Beta

0.12

Analyst view

Analysts rate BeyondSpring Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $1.25.

Shareholding

Insiders

14.26%

Institutions

14.58%

Largest institutional holders

Fund	Stake
Decheng Capital LLC	9.24%
Vanguard Group Inc	1.85%
BlackRock Inc	1.58%
Vanguard Capital Management, LLC	1.48%
Geode Capital Management, LLC	0.91%
State Street Corp	0.56%
Vanguard Fiduciary Trust Co	0.44%
Northern Trust Corp	0.17%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for BeyondSpring Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.